YCM
CTOR

Yakira Capital Management’s Citius Oncology CTOR Stock Holding History

Yakira Capital Management’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,999
Closed -$11.2K – 239
2025
Q1 		$11.2K Hold
11,999
– – ﹤0.01% 150
2024
Q4 		$13.8K Sell
11,999
-3,500
-23% -$3.93K 0.01% 157
2024
Q3 		$21.5K Sell
15,499
-209,501
-93% -$1.49M 0.01% 156
2024
Q2 		$2.56M Hold
225,000
– – 0.93% 43
2024
Q1 		$2.49M Hold
225,000
– – 0.75% 43
2023
Q4 		$2.46M Buy
+225,000
New +$2.45M 0.8% 40

Other funds holding CTOR

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Yakira Capital Management's CTOR Position: Q2 2025 in Review

Yakira Capital Management sold out of Citius Oncology (CTOR) in Q2 2025, closing a stake of 11,999 shares — an estimated $11.2K sold.

Yakira Capital Management first reported a position in CTOR in Q4 2023 and held it in 6 quarters. The position peaked at $2.56M in Q2 2024. 7 funds tracked by Wall St. Rank hold CTOR as of Q2 2025.

  • Yakira Capital Management reported no remaining Citius Oncology position as of Q2 2025 after selling out during the quarter.
  • Yakira Capital Management sold 11,999 Citius Oncology shares in Q2 2025, an estimated $11.2K.
  • Yakira Capital Management first reported a position in Citius Oncology in Q4 2023 and held it in 6 quarters.
  • Yakira Capital Management's Citius Oncology position peaked at $2.56M in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2025.

Based on Yakira Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.